Vascular Therapies

United States
Cresskill, New Jersey, United States
(201) 266-8310 ★

Company profile

Vascular Therapies company profile

Vascular Therapies (VT) is a biopharmaceutical company committed to the development and commercialization of innovative new treatments to address major unmet clinical needs of patients requiring a vascular access to support hemodialysis. Our lead product candidate, containing sirolimus, has received orphan drug designations in the U.S. and E.U. for the dialysis vascular access indications. The company was founded in 2001 and headquartered in Cresskill, New Jersey.

Business identity

Contact email
[email protected]
Phone number
(201) 266-8310
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$1K+
Founded
2001-01-01

Headquarters

Headquarters
Cresskill, New Jersey, United States
Postal code
07626
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
9
Total equity funding
$78.2M
Last funding
Series Unknown / $24M / 2022-03-04
Last equity funding
Series Unknown / $24M
Investors
2
Founders
1
Articles
11

Founders and investors

Founders

Sriram Iyer

Investors

CNF Investments, LLCSavitr Capital

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.